Focus: Element Science develops the Jewel Patch, a wearable cardioverter defibrillator designed to prevent sudden cardiac death in cardiovascular patients. The company operates as a specialized medical device manufacturer focused on a narrow, high-acuity indication.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Growing — net +9 jobs in 30d
9 jobs added vs 0 removed. Steady team buildout.
Element Science represents a speculative early-stage play best suited for risk-tolerant professionals seeking equity upside in a focused cardiovascular device company.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead product targeting prevention of sudden cardiac death via wearable patch technology.
Help build intelligence for Element Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Element Science's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles